Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Maxx Orthopedics Acquires TracPatch 

Maxx Orthopedics Acquires TracPatch 

On February 27, Maxx Orthopedics Inc. reported that it entered into an agreement to acquire TracPatch from Granger Group.   TracPatch is a non-invasive, FDA Class I exempt medical device that provides a digital health solution designed to provide accessible, connected and more predictable recovery. It provides surface-sensor, remote patient monitoring devices and data capture for musculoskeletal health. Granger Group purchased TracPatch in August 2023 for an undisclosed price.  Maxx Orthopedics is a manufacturer and developer of orthopedic medical devices and integrated solutions designed to restore mobility while addressing patient lifestyle, anatomical and economic... Read More »
QC Capital Announces Strategic Investment in My Pediatric Doctor

QC Capital Announces Strategic Investment in My Pediatric Doctor

Charlotte, North Carolina-based QC Capital Group has made a strategic investment in My Pediatric Doctor, adding the company to its portfolio. Financial terms of the deal were not disclosed. My Pediatric Doctor is a 24/7 acute urgent care pediatric-focused telemedicine platform delivering virtual healthcare to children in all 50 states, along with Guam and Puerto Rico. QC Capital Group is a private equity and alternative investment firm focused on building and scaling high-growth platforms across healthcare, real estate and operating businesses. Eric Doherty, an executive with a background in healthcare and operations, will helm the organization as CEO of My Pediatric Doctor, and will... Read More »
QC Capital Announces Strategic Investment in My Pediatric Doctor

Hims & Hers Announces Agreement to Acquire Eucalyptus

Hims & Hers Health, Inc., the leading health and wellness platform, announced on February 19 that it has entered into a definitive agreement to acquire Eucalyptus. As its U.S. business continues to grow, Hims & Hers will be positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the United Kingdom, Germany and Canada. Founded in 2019, Eucalyptus builds and operates a network of digital healthcare companies. The company has facilitated nearly two million consultations across Australia, the United Kingdom, Germany, Japan and Canada. Hims & Hers is a multi-specialty telehealth platform based in San Francisco, California. Hims... Read More »
TA Associates Sells PrimeRx to RedSail Technologies 

TA Associates Sells PrimeRx to RedSail Technologies 

William Blair announced that it acted as an advisor to PrimeRx throughout its acquisition by RedSail Technologies. The seller was TA Associates, who initially invested in PrimeRx in 2021.  Having closed on February 5, 2026, this transaction marked William Blair’s second signed or closed advisory deal in healthcare technology in 2026. Terms were not disclosed.  PrimeRx is a provider of pharmacy management software. The company’s software and services enable pharmacists to manage all clinical and operational aspects of their business, including prescription management, point-of-sale, signature capture and document/inventory management.  RedSail Technologies offers... Read More »
NuvemRx Acquires par8o from R1 RCM

NuvemRx Acquires par8o from R1 RCM

NuvemRx announced that it has acquired the 340B referral capture business formerly known as par8o from R1 RCM. Founded in 2011, par8o is a healthcare technology company specializing in 340B referral capture with expansive integrations with major pharmacy partners. par8o advances access to care for safety-net healthcare organizations by turning eligible outpatient referrals into compliant 340B savings at scale. par8o was acquired by R1 RCM as part of the Cloudmed transaction announced in December 2021. NuvemRx, backed by Parthenon Capital, helps community health providers deliver on their mission by simplifying the complexity of pharmacy operations. NuvemRx provides pharmacy–enablement and... Read More »
QC Capital Announces Strategic Investment in My Pediatric Doctor

Amwell Q4 Revenue Falls 22% Amid DHA Program Cuts

Amwell, a SaaS-based digital health platform for telehealth and hybrid care delivery, released fourth-quarter and full-year 2025 results on February 12, 2026. Top-line contraction stemmed mainly from the elimination of key Defense Health Agency (DHA) programs and attrition of older contracts, while the company narrowed losses through aggressive cost reductions and a strategic shift toward core payor and government clients. Amwell’s results reflect ongoing pressures from government contract changes (particularly DHA programs), with significant top-line erosion. Expense discipline and a targeted path to cash flow breakeven in Q4 2026 help offset some of this, though reimbursement... Read More »